Moscontin (Morphine Sulfate)

Morphine sulfate, the active ingredient in Moscontin, is an opioid analgesic presented as an extended‑release tablet for oral use. It treats moderate to severe acute pain, chronic cancer pain, severe postoperative pain, and chronic non‑cancer pain requiring opioid therapy in adult patients.

GNH USA supplies Moscontin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres, pharmacies and clinics worldwide.

Moscontin (morphine sulfate) is used for pain management across several clinical contexts.

- Moderate to severe acute pain: provides sustained analgesia for short‑term severe pain episodes. - Chronic cancer pain: offers continuous relief for persistent malignant pain. - Severe postoperative pain: maintains opioid levels after major surgery. - Chronic non‑cancer pain requiring opioid therapy: supplies long‑acting control for refractory pain conditions.

Moscontin may cause a range of adverse reactions, from mild to life‑threatening.

Common Side Effects: - Nausea: feeling of sickness often occurring after dosing. - Constipation: reduced bowel motility leading to hard stools. - Drowsiness: increased sleepiness or reduced alertness. - Dry mouth: decreased salivation causing oral discomfort.

Serious or Rare Side Effects: - Respiratory depression: slowed or shallow breathing that can be fatal. - Severe hypotension: marked drop in blood pressure causing dizziness. - Dependence/addiction: development of physical or psychological reliance. - Anaphylaxis: severe allergic reaction with hives, swelling, and airway compromise.

Before prescribing Moscontin, several safety considerations should be observed.

- Pain assessment: confirm that pain severity justifies opioid therapy. - Respiratory monitoring: watch for signs of respiratory depression, especially after dose changes. - Organ function: evaluate hepatic and renal function to adjust dosing if needed. - Respiratory disease: avoid or use with extreme caution in patients with severe asthma or COPD. - Lowest effective dose: start with the smallest dose that provides adequate relief. - Store at ambient temperature: keep in the original container, protect from moisture and heat.

Moscontin interacts with several drug classes that can alter its safety or efficacy.

Major Interactions (Avoid): - Central nervous system depressants (e.g., benzodiazepines, alcohol): additive sedation and respiratory depression. - Monoamine oxidase inhibitors: risk of severe hypertension or serotonin syndrome. - Strong CYP3A4 inhibitors (e.g., ketoconazole): increased morphine plasma levels.

Moderate Interactions (Monitor Closely): - CYP3A4 inducers (e.g., rifampin): reduced analgesic effect. - Serotonergic agents (e.g., SSRIs, SNRIs): potential for serotonin syndrome. - Antihistamines: may enhance sedation and dizziness.